Aralez Bio
Berkeley, US · Founded 2019 · 39 employees on LinkedIn · 8 known investors
Aralez Bio produces noncanonical amino acids using biocatalysis, including compounds that add rigidity to peptide backbones and increase enzyme resistance. The company manufactures these at multi-kilogram scale for peptide and pharmaceutical applications.
Founders & leadership
Aralez Bio was founded in 2019 by Tina Boville, David Romney, and Frances Arnold.
Investors · 8
.jpeg){kind=logo}
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AOct 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Aralez Bio do?
- Aralez Bio produces noncanonical amino acids using biocatalysis, including compounds that add rigidity to peptide backbones and increase enzyme resistance. The company manufactures these at multi-kilogram scale for peptide and pharmaceutical applications.
- Who founded Aralez Bio?
- Aralez Bio was founded by Tina Boville, David Romney, Frances Arnold in 2019.
- Who are Aralez Bio's investors?
- Aralez Bio's investors include Astia, Fifty Years, FREEFLOW, Good Growth Capital, ISV, Juniper, Paladin Capital Group, Spero Ventures.
- Where is Aralez Bio headquartered?
- Aralez Bio is headquartered in Berkeley, US.